9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Estimated reading time: < 1 min

Condition: Malignant Mesothelioma

Estimated Enrollment: 57

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Estimate overall survival,  qualitative and quantitative toxicities,  confirmed and unconfirmed complete and partial response,

Interventions: gemcitabine hydrochloride,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: June 2007

Completion Date: December 2007

Last  Posted Date: October 8, 2012

Location: MBCCOP – University of South Alabama, Mobile, Alabama, United States

Website Link: https://ClinicalTrials.gov/show/NCT00003723

Was this article helpful?
Dislike 0